Bullboard - Stock Discussion Forum Ensysce Biosciences Inc ENSCW

Primary Symbol: ENSC

Healthcare Biotechnology

Ensysce Biosciences, Inc. is a clinical-stage pharmaceutical company. The Company develops solutions for severe pain relief while reducing the potential for opioid misuse, abuse, and overdose. Its pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection (TAAP) platform, and an over-dose protection opioid prodrug technology... see more

Add To Watchlist

NDAQ:ENSC - Post Discussion

Ensysce Biosciences Inc > ENSC.... Seems to me that this should go much higher

View:

Post by Iseneschal on May 09, 2023 9:10am

ENSC.... Seems to me that this should go much higher

Based on past performance..... ENSC traded almost 4.5 million shares on 04/19/23 just on this NR:

Ensysce CEO Dr. Lynn Kirkpatrick To Present Featured Case Study of MPAR Overdose Protection Platform Accelerated Development

Todays Nr is " Ground-Breaking".... Here it is again :

Ensysce Biosciences Announces Successful Completion of Ground-Breaking Study on Overdose Protection

2023-05-09 05:02 ET - News Release

~ Represents Major Milestone Towards Launch of PF614-MPAR ~

~ PF614-MPAR on Track to be the First Drug to Protect Against Overdose ~

SAN DIEGO, CA / ACCESSWIRE / May 9, 2023 / Ensysce Biosciences, Inc. (NASDAQ:ENSC), clinical-stage biotech company applying transformative chemistry to improve prescription drug safety, today announced completion of PF614-MPAR-101, a clinical study examining the Company's first pain medication with overdose protection, PF614-MPAR. The final Part B of the study examined dose escalation of PF614-MPAR from 25 to 200 mg (1 to 8 dose units) and showed that PF614-MPAR successfully reduced opioid delivery when three or more doses are consumed simultaneously.